Protara Therapeutics

Clinical-stage biopharma developing TARA-002 cell therapy and IV choline chloride for cancer and rare disease patients

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-14

About Protara Therapeutics

Protara Therapeutics is a biopharmaceutical company developing therapies for people with cancer and rare diseases. Its lead investigational product, TARA-002, is a cell therapy based on the immunopotentiator OK-432, which is approved in Japan and Taiwan for several oncologic indications and lymphatic malformations.

The company is evaluating TARA-002 for non-muscle invasive bladder cancer and lymphatic malformations in the U.S.; the FDA has granted it Rare Pediatric Disease Designation. Its other investigational product, IV Choline Chloride, is a phospholipid substrate replacement therapy for patients on parenteral support.

Protara was founded on applying modern scientific, regulatory or manufacturing advances to established mechanisms. It is listed on NASDAQ, and its offices are located in the Flatiron District of New York City, where it has open roles in legal, medical affairs and clinical operations.

Product: TARA-002, an investigational OK-432-based cell therapy, and IV Choline Chloride, an investigational phospholipid substrate replacement therapy.

Jobs at Protara Therapeutics

No open positions listed right now.

More biotech & pharma companies

  • Ptcbio

    Biopharmaceutical company developing and commercializing medicines for children and adults with serious rare diseases
    United StatesBiotech & pharma4 open jobs
    New on EvolcRemote-friendly
  • Pulmovant

    Developing inhaled therapies for patients with pulmonary diseases, starting with pulmonary hypertension associated
    United StatesBiotech & pharma
    New on Evolc
  • Ratiotx

    Develops targeted radiopharmaceuticals for treating cancer, from discovery through early clinical trials
    United StatesBiotech & pharma
    New on Evolc
  • ReCode Therapeutics

    Develops mRNA and gene-correction medicines for people with genetically defined diseases, including cystic fibrosis
    United StatesBiotech & pharma
    New on Evolc
  • Recursion

    AI-enabled drug discovery and development for pharmaceutical partners and patients with oncology and rare diseases
    United StatesBiotech & pharma1 open job
    Remote-friendlySalary transparent
  • Remix Therapeutics

    Clinical-stage biotech developing small-molecule mRNA degraders for solid tumors and blood cancers
    United StatesBiotech & pharma
    New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Analytics

  • Google Analytics 4High confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • MatomoMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Content management

  • ElementorHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • WordPressHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Forms

  • Google reCAPTCHAHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • jQueryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Hosting

Recruiting

  • GreenhouseHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.